Evidence map›Paper›PMID 41749939›Full record

ReviewCancers2026

Soluble B-Cell Maturation Antigen as a Prognostic Marker for Progression-Free Survival in Multiple Myeloma Treated with BCMA-Directed Therapies: A Systematic Review and Meta-Analysis.

Artur Borkowski, Ugo Giordano, Wojciech Szlasa, Krzysztof Dudek, Karolina Kędziora, Monika Mordak-Domagała, Zuzanna Dybko, Jacek Kwiatkowski, Jarosław Dybko

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Artur BorkowskiClinical Endocrinology Department, 4th Military Clinical Hospital, 50-981 Wrocław, Poland.ORCID 0000-0002-1019-8976
Ugo GiordanoDepartment and Clinic of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, 50-367 Wrocław, Poland.ORCID 0009-0000-8735-3076
Wojciech SzlasaLower Silesia Centre for Oncology, Pulmonology and Hematology in Wrocław, 53-439 Wrocław, Poland.
Krzysztof DudekCentre for Research and Innovation, 4th Military Clinical Hospital, 50-981 Wrocław, Poland.ORCID 0000-0002-9442-989X
Karolina KędzioraLower Silesia Centre for Oncology, Pulmonology and Hematology in Wrocław, 53-439 Wrocław, Poland.
Monika Mordak-DomagałaLower Silesia Centre for Oncology, Pulmonology and Hematology in Wrocław, 53-439 Wrocław, Poland.
Zuzanna DybkoFaculty of Medicine, Wroclaw Medical University, 50-367 Wrocław, Poland.
Jacek KwiatkowskiLower Silesia Centre for Oncology, Pulmonology and Hematology in Wrocław, 53-439 Wrocław, Poland.
Jarosław DybkoLower Silesia Centre for Oncology, Pulmonology and Hematology in Wrocław, 53-439 Wrocław, Poland.ORCID 0000-0003-3555-2887

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BCMA-directed therapiesmultiple myelomaprognostic biomarkersoluble B-cell maturation antigen

Identifiers

PMID41749939
PMCPMC12938959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.